Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

[30] Patch testing with the whole vaccine, as well as with its individual components in standardized concentrations and vehicles, was performed on the skin after resolution of the reaction.

LYON, France, and BANGKOK, Jan. 17, 2025 /PRNewswire/ -- BioNet, a global leader in vaccine innovation, proudly announces its selection as a Concept Stage winner in the prestigious United States ...

“Alternative vaccination platforms like Vaxxas’ patch technology can complement traditional needle and syringe delivery, helping us get more vaccines into arms to address emerging health problem ...

The Vaxxas HD-MAP is comprised of thousands of microscopic projections molded into a small patch. Each microprojection is coated with a small dose of vaccine in a dried formulation. When applied ...

Vaxxas, a clinical-stage biotechnology company, has announced the appointments of three globally respected vaccine experts as ...

Clinical-stage biotechnology company Vaxxas has appointed three global vaccine experts as advisors as it progresses its ...

Audicana and colleagues evaluated tolerance to thimerosal-containing vaccines in 125 patients sensitized to mercury derivatives and/or thimerosal. [23] Patch-test results in this patient ...